Successful Retreatment with Elotuzumab for Multiple Myeloma with Extramedullary Relapse while Being Treated with Lenalidomide and Dexamethasone.

Successful Retreatment with Elotuzumab for Multiple Myeloma with Extramedullary Relapse while Being Treated with Lenalidomide and Dexamethasone. Pathol Oncol Res. 2019 Aug 22;: Authors: Oka S, Ono K, Nohgawa M PMID: 31440905 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31440905?dopt=Abstract

Source: Pathology Oncology Research - August 21, 2019 Category: Pathology Authors: Oka S, Ono K, Nohgawa M Tags: Pathol Oncol Res Source Type: research

More News: Cancer & Oncology | Dexamethasone | Myeloma | Pathology | Revlimid